CKD Bio Corp. (KRX:063160)

CKD Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Nov 20, 2025	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Market Capitalization	114,931	130,566	229,313	438,328	158,885	106,437
Market Cap Growth	-18.16%	-43.06%	-47.69%	175.88%	49.28%	68.02%
Enterprise Value	261,711	251,285	333,496	515,471	171,618	114,125
Last Close Price	20950.00	23691.32	41609.13	79343.05	29214.98	19440.71
PE Ratio	-	-	-	70.61	12.95	13.38
PS Ratio	0.72	0.84	1.61	3.52	1.16	0.86
PB Ratio	0.87	0.88	1.42	2.60	1.00	0.72
P/TBV Ratio	0.91	0.91	1.45	2.64	1.01	0.73
P/OCF Ratio	-	-	-	90.86	9.35	6.85
EV/Sales Ratio	1.64	1.61	2.35	4.14	1.25	0.92
EV/EBITDA Ratio	-	80.34	60.07	25.98	6.81	7.15
EV/EBIT Ratio	-	-	-	67.76	11.14	16.28
EV/FCF Ratio	-11.46	-	-	-	-	-
Debt / Equity Ratio	1.21	0.94	0.68	0.47	0.18	0.03
Debt / EBITDA Ratio	-	44.41	19.70	4.02	1.13	0.31
Asset Turnover	0.51	0.51	0.49	0.48	0.66	-
Inventory Turnover	2.04	1.87	1.99	2.14	3.38	-
Quick Ratio	0.65	0.49	0.76	0.58	1.06	2.03
Current Ratio	1.56	1.51	2.36	1.92	1.78	3.31
Return on Equity (ROE)	-16.26%	-10.80%	-3.98%	3.79%	8.01%	-
Return on Assets (ROA)	-4.96%	-3.03%	-2.46%	1.84%	4.61%	-
Return on Capital (ROIC)	-5.54%	-3.32%	-2.75%	2.18%	5.68%	-
Return on Capital Employed (ROCE)	-10.80%	-6.40%	-4.50%	3.20%	8.20%	4.40%
Earnings Yield	-20.13%	-12.79%	-2.87%	1.42%	7.72%	7.47%
FCF Yield	-19.86%	-7.20%	-11.50%	-12.97%	-19.09%	-0.81%
Dividend Yield	0.48%	-	0.24%	0.25%	0.65%	0.98%
Payout Ratio	-	-	-	16.53%	8.36%	25.79%
Buyback Yield / Dilution	0.02%	-	-1.40%	-0.46%	0.00%	0.03%
Total Shareholder Return	0.49%	-	-1.16%	-0.20%	0.65%	1.01%

Updated Nov 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.